News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Cunningham Emmett
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/16/2023 |
4
| Cunningham Emmett (Director) has filed a Form 4 on Galera Therapeutics, Inc.
Txns:
| Granted 48,000 options to buy
@ $3.27, valued at
$157k
|
|
06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/23/2020 |
3
| Cunningham Emmett (Director) has filed a Form 3 on Annexon, Inc. |
06/10/2020 |
4
| Cunningham Emmett (Director) has filed a Form 4 on Galera Therapeutics, Inc.
Txns:
| Granted 9,888 options to buy
@ $9.31, valued at
$92.1k
|
|
04/07/2020 |
4
| Cunningham Emmett (Director) has filed a Form 4 on LUMOS PHARMA, INC.
Txns:
| Granted 709 shares
@ $0 Granted 5,684 options to buy
@ $7.78, valued at
$44.2k
|
|
03/30/2020 |
3
| Cunningham Emmett (Director) has filed a Form 3 on LUMOS PHARMA, INC. |
11/08/2019 |
4
| Cunningham Emmett (Director) has filed a Form 4 on Galera Therapeutics, Inc.
Txns:
| Granted 19,776 options to buy
@ $12, valued at
$237.3k
|
|
11/06/2019 |
3
| Cunningham Emmett (Director) has filed a Form 3 on Galera Therapeutics, Inc. |
10/11/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|